Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus-Reference-Cited by-同舟云学术

Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus

Published:2023-01-11 Issue:3 Volume:39 Page:
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metabolism Res

Author:

Ibrahim Mahmoud¹^ORCID,Barker Mary Moffett²,Ahmad Ehtasham²^ORCID,Ahmed Asma³,Annabi Firas A.⁴,Ba‐Essa Ebtesam M.⁵,Davies Melanie J.²,Houeiss Pamela⁶^ORCID,Iraqi Hinde⁷,Masood Shabeen Naz⁸,Mimouni‐Zerguini Safia⁹,Shaikh Shehla¹⁰,Tantawi Hyam¹¹,Tuomilehto Jaakko¹²¹³

Affiliation:

1. EDC Centre for Diabetes Education Charlotte North Carolina USA

2. Diabetes Research Centre University of Leicester Leicester UK

3. Agha Khan University Hospital Karatchi Pakistan

4. Islamic Hospital Amman Jordan

5. Sumuo Medical Centre Dammam Saudi Arabia

6. Medical Faculty Paris University Paris France

7. Faculty of Medicine and Pharmacy Department of Endocrinology Mohamed V University Rabat Morocco

8. Department of Obstetrics and Gynecology Isra University Karachi Pakistan

9. Department of Endocrinology, Diabetology & Metabolic Diseases Pierre & Marie Curie Center University of Algiers Alger Ctre Algeria

10. Saifee Hospital Mumbai India

11. Ain Shams University Cairo Egypt

12. Public Health Promotion Unit Finnish Institute for Health and Welfare Helsinki Finland

13. Diabetes Research Unit King Abdulaziz University Jeddah Saudi Arabia

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.3604

Reference35 articles.

1. Recommendations for Management of Diabetes During Ramadan

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations;Diabetes, Metabolic Syndrome and Obesity;2023-11